North Rock Partners, LLC Amgen Inc Transaction History

North Rock Partners, LLC

$1.14 Billion
Q3 2024

A detailed history of North Rock Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, North Rock Partners, LLC holds 4,228 shares of AMGN stock, worth $1.35 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

4,228

Previous 4,183 1.08%

Holding current value

$1.35 Million

Previous $1.31 Million 4.29%

% of portfolio

0.12%

Previous 0.11%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$309.38 - $337.38 $13,922 - $15,182	45 Added 1.08%	4,228 $1.36 Million
Q2 2024 Aug 06, 2024	SELL	$262.75 - $319.31 $121,916 - $148,159	-464 Reduced 9.98%	4,183 $1.31 Million
Q1 2024 May 07, 2024	BUY	$268.87 - $324.56 $145,996 - $176,236	543 Added 13.23%	4,647 $1.32 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $61,368 - $69,230	240 Added 6.21%	4,104 $1.18 Million
Q3 2023 Oct 24, 2023	BUY	$218.65 - $271.46 $407,563 - $506,001	1,864 Added 93.2%	3,864 $1.04 Million
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $105,635 - $124,911	-493 Reduced 19.78%	2,000 $444,000
Q1 2023 May 03, 2023	SELL	$225.79 - $275.2 $74,510 - $90,816	-330 Reduced 11.69%	2,493 $602,000
Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $32,522 - $41,323	142 Added 5.3%	2,823 $741,000
Q3 2022 Nov 02, 2022	SELL	$224.46 - $253.15 $345,892 - $390,104	-1,541 Reduced 36.5%	2,681 $604,000
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $354,370 - $394,352	1,536 Added 57.19%	4,222 $1.03 Million
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $231,768 - $256,396	1,057 Added 64.89%	2,686 $650,000
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $35,002 - $40,057	176 Added 12.11%	1,629 $367,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $73,657 - $86,298	347 Added 31.37%	1,453 $309,000
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $258,339 - $286,608	1,106 New	1,106 $270,000
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $201,666 - $240,148	-932 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $18,772 - $20,876	80 Added 9.39%	932 $237,000
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $395 - $485	-2 Reduced 0.23%	852 $201,000
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $132,334 - $162,393	-669 Reduced 43.93%	854 $201,000
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $189,711 - $251,609	-1,041 Reduced 40.6%	1,523 $309,000
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $189 - $243	-1 Reduced 0.04%	2,564 $618,000
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $217,780 - $279,923	1,151 Added 81.4%	2,565 $618,000
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $246,191 - $294,988	1,414 New	1,414 $274,000

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.

Account

North Rock Partners, LLC Amgen Inc Transaction History